Latanoprost + Timolol Ratiopharm (Timolol Maleate, Latanoprost)

• Latanoprost + Timolol Ratiopharm is indicated for conditions involving elevated intraocular pressure.
• Open‑angle glaucoma: reduces intraocular pressure to protect the optic nerve and preserve visual field.
• Ocular hypertension: lowers eye pressure to reduce the risk of progression to glaucoma.
• Pseudoexfoliative glaucoma: helps control pressure in this secondary form of open‑angle glaucoma.
• Secondary glaucoma: provides pressure reduction when monotherapy is insufficient.
• Normal tension glaucoma: may be used as adjunct to achieve target pressure.

• Latanoprost, a prostaglandin F2α analog, binds to FP receptors in the ciliary body, enhancing uveoscleral outflow of aqueous humor. Timolol maleate, a non‑selective β‑adrenergic antagonist, blocks β1 and β2 receptors in the ciliary epithelium, decreasing aqueous humor production. This dual mechanism allows effective pressure control with lower individual drug concentrations, improving tolerability while maintaining therapeutic efficacy.

Latanoprost + Timolol Ratiopharm may cause ocular and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Eye irritation: mild burning or stinging upon instillation.
• Redness: conjunctival hyperemia.
• Blurred vision: transient visual disturbance after dosing.
• Dry eye: decreased tear production.
• Headache: mild to moderate headache.
• Foreign body sensation: feeling of something in the eye.

Serious or Rare Side Effects

• Severe allergic reaction: swelling, rash, or anaphylaxis.
• Bronchospasm: difficulty breathing, especially in asthmatic patients.
• Marked bradycardia: significant slowing of heart rate.
• Hypotension: systemic low blood pressure.
• Ocular inflammation: uveitis or keratitis.

• Before prescribing Latanoprost + Timolol Ratiopharm, clinicians should consider several safety precautions to minimize risks.
• Assess cardiovascular status: patients with bradycardia, heart block, or heart failure require careful evaluation.
• Monitor intraocular pressure: ensure adequate pressure reduction and adjust therapy as needed.
• Avoid use in patients with known hypersensitivity: discontinue if allergic reactions occur.
• Caution in pregnancy: safety not established; use only if potential benefit justifies risk.
• Avoid concurrent ocular medications: separate administration by at least five minutes.
• Store at room temperature: keep in original container, protect from light and moisture.

Latanoprost + Timolol Ratiopharm can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

• Systemic non‑selective β‑blockers: additive bradycardia or hypotension may occur.
• Sympathomimetic ophthalmic agents (e.g., epinephrine): may diminish intraocular pressure‑lowering effect.
• Anticholinergic eye drops: can interfere with pupil dynamics and increase pressure.

Moderate Interactions (Monitor Closely)

• Other ocular hypotensive agents: combined use may increase risk of ocular irritation.
• Systemic steroids: may counteract pressure‑lowering effect.
• MAO inhibitors: potential for hypertensive episodes when combined with prostaglandin analogs.